Palisade Capital Management, Lp
Source: SEC Form 13F · as of Mar 2026Palisade Capital Management, Lp holds 17 biotech & pharma companies tracked by BioSniper, totaling $125.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$125.4M
| Company | Shares | Value |
|---|---|---|
| RGENREPLIGEN CORP | 240,619 | $28.3M |
| ABBVAbbVie Inc. | 71,165 | $15.5M |
| ACHCAcadia Healthcare Company Inc. | 613,372 | $14.3M |
| CSTLCastle Biosciences Inc. | 535,884 | $13.2M |
| EBSEmergent BioSolutions Inc. | 1,201,323 | $10.0M |
| LLYELI LILLY & Co | 9,475 | $8.7M |
| AXSMAxsome Therapeutics, Inc. | 40,563 | $6.9M |
| ICLRICON plc | 58,150 | $6.4M |
| JNJJOHNSON & JOHNSON | 23,396 | $5.7M |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 6,140,639 | $4.9M |
| NVONovo Nordisk A/S | 115,043 | $4.2M |
| LGNDLigand Pharmaceuticals Incorporated | 20,525 | $4.1M |
| PMPhilip Morris International Inc | 11,775 | $1.9M |
| GILDGILEAD SCIENCES, INC. | 2,742 | $382K |
| AZNASTRAZENECA PLC | 1,577 | $311K |
| MRKMerck & Co., Inc. | 2,014 | $242K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 884 | $239K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.